Mirae Asset Global ETFs Holdings’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
117,682
+40,390
+52% +$121K ﹤0.01% 2183
2026
Q1
$235K Buy
77,292
+24,726
+47% +$105K ﹤0.01% 2278
2025
Q4
$190K Buy
52,566
+6,661
+15% +$29K ﹤0.01% 2375
2025
Q3
$173K Sell
45,905
-1,443
-3% -$5.57K ﹤0.01% 2395
2025
Q2
$181K Sell
47,348
-1,553
-3% -$8.4K ﹤0.01% 2327
2025
Q1
$247K Buy
48,901
+2,241
+5% +$14.2K ﹤0.01% 2217
2024
Q4
$337K Buy
46,660
+1,540
+3% +$11.8K ﹤0.01% 2106
2024
Q3
$279K Buy
45,120
+9,118
+25% +$61.8K ﹤0.01% 2198
2024
Q2
$237K Buy
+36,002
New +$266K ﹤0.01% 2168

Other funds holding ALT

Mirae Asset Global ETFs Holdings's ALT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Altimmune (ALT) stake by 52% in Q2 2026, buying an estimated $121K and bringing the position to 117,682 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

Mirae Asset Global ETFs Holdings first reported a position in ALT in Q2 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 117,682 shares of Altimmune worth $355K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 40,390 Altimmune shares in Q2 2026, an estimated $121K.
  • Altimmune made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2183 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Altimmune in Q2 2024 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.